aim
research
investig
blood
coagul
function
patient
avascular
necrosi
femor
head
anfh
sever
acut
respiratori
syndrom
sar
express
platelet
membran
measur
respect
flowcytometri
plasma
prothrombin
time
pt
activ
partial
thromboplastin
time
aptt
thrombin
time
tt
fibrinogen
fbg
measur
blood
clot
instrument
patient
anfh
sar
healthi
adult
express
cd
platelet
membran
patient
lower
healthi
subject
p
level
pt
aptt
tt
fbg
patient
normal
signific
differ
p
marker
patient
healthi
adult
blood
may
hypercoagul
state
patient
anfh
sar
twentysix
patient
avascular
necrosi
femor
head
anfh
sever
acut
respiratori
syndrom
sar
treat
depart
septemb
april
marker
relat
blood
coagul
includ
cd
platelet
membran
plasma
prothrombin
time
pt
activ
partial
thromboplastin
time
aptt
thrombin
time
tt
fibrinogen
fbg
measur
respect
investig
blood
coagul
function
etiolog
anfh
sar
twentysix
patient
age
year
mean
year
anfh
sar
enrol
studi
patient
eight
male
femal
seventeen
case
medic
staff
episod
diseas
administ
radioson
dose
mg
day
experienc
slight
seriou
discomfort
pain
site
hipjoint
four
six
month
administr
hormon
confirm
avascular
necrosi
femor
head
magnet
reson
imag
mri
examin
diseas
belong
stage
ii
accord
classif
associ
research
circul
osseou
arco
patient
return
hospit
visit
doctor
three
four
month
discharg
hospit
addit
healthi
volunt
collect
serv
control
group
subject
six
case
male
case
femal
age
rang
year
old
median
age
year
signific
statist
differ
gender
age
two
group
p
patient
experienc
discomfort
pain
site
hipjoint
four
six
month
administr
hormon
blood
sampl
taken
intraven
condit
fast
measur
platelet
membran
coagul
four
indic
includ
pt
aptt
fbg
tt
blood
sampl
taken
take
anticoagul
drug
platelet
suppress
drug
reagent
includ
fitclabel
human
antibodi
percplabel
human
antibodi
pelabel
human
antibodi
pelabel
human
antibodi
fitclabel
human
antibodi
provid
american
b
dpbarm
ingen
corpor
coagul
four
indic
reagent
provid
japanes
eastasia
corpor
calibur
flow
cytomet
provid
american
bd
corpor
blood
coagul
instrument
model
number
provid
japanes
eastasia
corpor
statist
softwar
use
data
express
x
rp
analyz
method
ttest
express
platelet
membran
necrosi
group
lower
control
group
p
signific
differ
p
coagul
four
indic
includ
pt
aptt
fbg
tt
patient
healthi
subject
demonstr
tabl
accord
relev
data
found
half
patient
would
suffer
anfh
recov
sar
chen
report
incid
previous
research
anfh
show
administr
hormon
common
reason
anfh
soucaco
found
case
anfh
result
use
corticoid
report
maxim
dose
administ
sar
patient
mgd
addit
durat
administr
almost
within
one
month
incid
anfh
direct
correl
use
hormon
doubt
hormon
import
reason
diseas
agreement
among
mani
pathogenesi
explain
hormon
result
anfh
includ
theori
lipin
metabol
disturb
intravascular
coagul
theori
osteoporosi
theori
theori
sediment
immun
complex
result
arteri
vascul
theori
venostasi
result
highpressur
bone
theori
hormon
toxic
effect
bone
cell
wang
perform
studi
found
administr
larg
dose
hormon
short
time
could
make
blood
hypercoagul
state
liu
thought
episod
anfh
abnorm
blood
coagul
present
zheng
found
hormon
could
result
high
coagul
earli
activ
platelet
date
report
discuss
platelet
membran
glycoprotein
tetrachor
coagul
found
patient
anfh
sar
express
glycoprotein
platelet
membran
decreas
coagul
four
indic
includ
pt
aptt
tt
time
normal
content
fbg
also
normal
indic
high
blood
coagul
patient
found
anfh
consist
result
acquir
wang
conduct
studi
blood
coagul
function
sar
patient
found
pt
aptt
prolong
remark
fbg
signific
rise
acut
stage
episod
becam
normal
three
month
diseas
cure
glycoprotein
platelet
membran
play
part
adhes
releas
aggreg
platelet
marker
activ
platelet
studi
express
glycoprotein
platelet
membran
decreas
suggest
platelet
activ
reason
might
follow
express
glycoprotein
platelet
membran
impair
structur
destroy
sar
viru
larg
dose
hormon
administr
du
report
level
glycoprotein
gpiibiiia
platelet
membran
asthmat
patient
remiss
stage
higher
normal
patient
activ
rate
platelet
increas
decreas
glucocorticoid
inhal
immunolog
function
inhibit
administr
larg
quantiti
glucocorticoid
result
damag
immunolog
function
autoantibodi
produc
patient
infect
viru
epitop
famili
mostli
locat
glycoprotein
gpiibiiia
platelet
membran
meantim
glycoprotein
platelet
membran
impact
enclosur
antibodi
lost
function
adhes
aggreg
larg
quantiti
antibiot
appli
coagul
four
indic
could
reflect
blood
coagul
function
human
bodi
among
pt
mostli
reflect
content
activ
coagul
factor
rout
extrins
coagul
aptt
mostli
reflect
content
activ
coagul
factor
rout
intrins
coagul
tt
reflect
whether
blood
antithrombot
increas
fbg
princip
coagul
factor
blood
coagul
system
also
accessori
factor
platelet
aggreg
platelet
activ
spatial
configur
chang
fibrinogen
receptor
expos
identif
incorpor
fibrinogen
platelet
could
facilit
thu
platelet
aggreg
coagul
four
indic
normal
indic
content
intern
extrins
coagul
factor
anfh
patient
sar
normal
blood
hypercoagul
meantim
indirectli
prove
platelet
activ
blood
coagul
system
initi
accord
decreas
express
glycoprotein
platelet
membran
base
comprehens
analysi
found
blood
hypercoagul
patient
suffer
anfh
sar
possibl
reason
includ
hormon
administ
larg
dose
short
time
sar
viru
imping
platelet
activ
immunosuppress
applic
antibiot
abnorm
antithrombot
blood
present
consequ
infer
anfh
sar
may
develop
mechan
abnorm
blood
coagul
howev
sever
marker
relat
blood
coagul
measur
possibl
special
blood
coagul
substanc
blood
patient
anfh
sar
need
studi
